Decreased nitric oxide in women with essential hypertension in prehypertensive phase

Croatian Medical Journal

Volumn 46, Issue 6, 2005, Pages 889-893

  Gerasimovska Kitanovska, Biljana ^a   Zafirovska, Katica ^a   Bogdanovska, Stevka ^a   Lozance, Ljubinka ^a   Severova Andreevska, Galina ^a  

^a SS CYRIL AND METHODIUS UNIVERSITY   (Macedonia)

Author keywords

[No Author keywords available]

Indexed keywords

6 OXOPROSTAGLANDIN F1 ALPHA; CALCIUM ION; CREATININE; ELECTROLYTE; NITRIC OXIDE; POTASSIUM ION; SODIUM ION; THROMBOXANE B2; VASOACTIVE AGENT;

ADULT; ARTICLE; BLOOD PRESSURE; BLOOD PRESSURE MONITORING; BLOOD VESSEL REACTIVITY; BLOOD VESSEL TONE; CALCIUM URINE LEVEL; CLINICAL ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CORRELATION ANALYSIS; DIASTOLIC BLOOD PRESSURE; ESSENTIAL HYPERTENSION; FEMALE; HOSPITAL DEPARTMENT; HUMAN; MACEDONIA (REPUBLIC); MEAN ARTERIAL PRESSURE; MULTIPLE REGRESSION; NATRIURESIS; STATISTICAL SIGNIFICANCE; SYSTOLIC BLOOD PRESSURE; URINALYSIS;

6-KETOPROSTAGLANDIN F1 ALPHA; ADULT; CASE-CONTROL STUDIES; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; HYPERTENSION; NITRIC OXIDE; THROMBOXANE B2; TIME FACTORS; VASOCONSTRICTION; VASODILATION;

EID: 31744438946     PISSN: 03539504     EISSN: 13328166     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Haller H. Hypertension, the endothelium and the pathogenesis of chronic vascular disease. Kidney Blood Press Res. 1996;19:166-71.
2. Node K, Kitakaze M, Yoshikawa H, Kosaka H, Hori M. Reduced plasma concentrations of nitrogen oxide in individuals with essential hypertension. Hypertension. 1997;30(3 Pt 1):405-8.
3. Luscher TF, Barton M. Biology of the endothelium. Clin Cardiol. 1997;20(11 Suppl 2):II-3-10.
4. Galle J, Wanner C. Impact of nitric oxide on renal hemodynamics and glomerular function: modulation by atherogenic lipoproteins? Kidney Blood Press Res. 1996;19:2-15.
5. Dunn MJ. Renal prostaglandins. In: Dunn MJ, editor. Renal endocrinology. Baltimore (MD): Williams & Wilkins; 1983. p. 1-74.
6. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension. 2003;42:1206-52.
7. Conrad KP, Joffe GM, Kruszyna H, Kruszyna R, Rochelle LG, Smith RP, et al. Identification of increased nitric oxide biosynthesis during pregnancy in rats. FASEB J. 1993;7:566-71.
8. Qureshi AI, Suri MF, Kirmani JF, Divani AA. Prevalence and trends of prehypertension and hypertension in United States: National Health and Nutrition Examination Surveys 1976 to 2000. Med Sci Monit. 2005;11:CR403-9.
9. Furchgott RF, Zawadzki JV. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature. 1980;288:373-6.
10. Forte P, Copland M, Smith LM, Milne E, Sutherland J, Benjamin N. Basal nitric oxide synthesis in essential hypertension. Lancet. 1997;349:837-42.
11. Cosenzi A, Franca G, Piemontesi A, Bellini G. Correlations between calciuria and systolic arterial pressure in young normotensive subjects with family history of hypertension [in Italian]. G Clin Med. 1989;70:19-25.
12. Haddy FJ. Roles of sodium, potassium, calcium, and natriuretic factors in hypertension. Hypertension. 1991;18(5 Suppl):III179-83.
13. Calver A, Collier J, Moncada S, Vallance P. Effect of local intra-arterial NG-monomethyl-L-arginine in patients with hypertension: the nitric oxide dilator mechanism appears abnormal. J Hypertens. 1992;10:1025-31.